PROTOPAM CHLORIDE: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare Corp	PROTOPAM CHLORIDE	pralidoxime chloride	INJECTABLE;INJECTION	014134	NDA	Baxter Healthcare Corporation	60977-141-01	6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) / 20 mL in 1 VIAL, SINGLE-DOSE (60977-141-27)	1965-03-10
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 4, 2025

Introduction

Protopam Chloride, also known as pralidoxime chloride, is a critical antidote used in the treatment of organophosphorus poisoning, including nerve agents and pesticide overdoses. Its timely administration can significantly improve patient outcomes by reactivating acetylcholinesterase and reversing the toxic effects of organophosphates. As demand for this life-saving drug persists globally, understanding its primary suppliers becomes essential for healthcare providers, government agencies, and pharmaceutical distributors seeking reliable sources.

Overview of Protopam Chloride

Protopam Chloride is a sterile, injectable antidote primarily manufactured in pharmaceutical-grade, injectable formulations. It features a complex synthesis process, stringent quality control standards, and tight regulatory oversight, which together limit the number of qualified producers globally. The drug’s importance in emergency medicine, military applications, and agrochemical safety bolsters its procurement significance across various markets.

Major Global Suppliers of Protopam Chloride

The supply chain for Protopam Chloride involves several well-established pharmaceutical companies, particularly those specializing in antidotes, emergency medicines, and specialty pharmaceuticals. These companies operate manufacturing facilities compliant with international Good Manufacturing Practices (GMP), ensuring quality, safety, and efficacy.

1. QPS (Queenston Pharmacal & Scientific)

Overview: QPS, based in South Africa, is a prominent supplier of Pralidoxime Chloride globally, particularly serving African, Middle Eastern, and European markets. They manufacture and distribute various antidotes, including Protopam Chloride.
Capabilities: QPS supplies injectable pralidoxime chloride in ampoule and vial forms, adhering to WHO GMP standards. They have strategic distribution channels aligned with international health organizations.
Certification: Certified by several regulatory agencies and compliant with international pharmacopoeial standards (USP, BP, Ph. Eur.).

2. Pfizer Inc.

Overview: Pfizer is a leading multinational pharmaceutical company with a long history of producing emergency and antidote medications, including pralidoxime chloride.
Manufacturing: Pfizer manufactures Protopam Chloride in their US-based facilities, distributing globally. Their production volume and extensive regulatory approval streamline supply reliability.
Market Focus: Supplies primarily to North American and European markets, with strategic distribution to other regions through partnerships.

3. BioPharmX Corporation

Overview: BioPharmX is a specialty pharmaceutical company involved in manufacturing injectable antidotes, including Protopam Chloride.
Capabilities: Their facilities are GMP-certified, with a focus on crisis response medications. They supply to government agencies and hospital networks.
Distribution Network: Focuses on North American and select international markets.

4. Indian Pharmaceutical Manufacturers

Several Indian pharmaceutical firms play a pivotal role in the global supply chain, especially in generic formulations of Protopam Chloride.
- Hetero Drugs Limited: Known for producing injectable antidotes, Hetero supplies to Asia, Africa, and Latin America.
- Natco Pharma: Provides pralidoxime chloride formulations for emerging markets, with a focus on affordability and supply flexibility.
Regulatory Certification: These companies often possess CDSCO (Central Drugs Standard Control Organization) approval, facilitating exports under WHO prequalification schemes.

Regional Suppliers and Local Distributors

Many regional pharmaceutical companies and distributors in Asia, Africa, and Eastern Europe offer Protopam Chloride to local markets, often as generic formulations. These suppliers typically operate under licensing agreements with major global manufacturers, ensuring standards compliance.

Examples include:
- API manufacturing companies producing bulk pralidoxime chloride for formulation.
- Regional distributors sourcing from Indian and Chinese manufacturers to distribute within their respective markets.

Assessment of Supplier Reliability and Regulatory Compliance

Procurement decisions should prioritize suppliers with:

Regulatory Approvals: Ensuring compliance with WHO prequalification, US FDA, EMA, or national regulatory agencies.
Quality Assurance: Certification of GMP and quality standards.
Supply Chain Stability: Evidence of consistent production capacity, contingency planning, and distribution networks.
Traceability: Transparent sourcing of raw materials and adherence to international pharmacovigilance standards.

Emerging Trends and Future Supply Dynamics

The global demand for antidotes like Protopam Chloride is projected to increase due to rising awareness of chemical safety and terrorist threat preparedness. Manufacturers invest in expanding production capacity and establishing strategic stockpiles. Governments and NGOs increasingly collaborate with established suppliers to ensure access in high-risk regions, promoting technology transfer and local manufacturing initiatives to bolster supply resilience.

Conclusion

The supply of Protopam Chloride hinges on a handful of established multinational pharmaceutical companies, regional manufacturers, and generic drug producers, with logistical and regulatory factors shaping procurement landscapes. Ensuring a steady, high-quality supply requires close attention to regulatory compliance, manufacturing capacity, and strategic distribution networks.

Key Takeaways

Major global suppliers include Pfizer, QPS, BioPharmX, and Indian pharmaceutical firms like Hetero and Natco.
Suppliers must meet strict GMP and regulatory standards to ensure safety and efficacy.
Regional manufacturers and distributors play a vital role in supplying emerging markets, often through licensing and generic formulations.
Supply chain resilience depends on diversified sourcing, regulatory compliance, and contingency planning.
Growing demand underscores the need for strategic partnerships to secure reliable access to this critical antidote.

FAQs

1. What are the primary regulatory considerations when sourcing Protopam Chloride?
Procurement must ensure suppliers have GMP certification and relevant regulatory approvals (e.g., WHO prequalification, FDA, EMA) to guarantee product quality and safety.

2. How does the manufacturing process affect the supply availability of Protopam Chloride?
The complex synthesis, stringent quality control, and raw material sourcing influence production capacity. Manufacturers with established, efficient processes are better positioned to meet global demand.

3. Are generic versions of Protopam Chloride reliable substitutes?
Yes, provided they are produced by licensed manufacturers meeting international standards. Regulatory approval and certification are key indicators of reliability.

4. Which regions face the greatest supply challenges for Protopam Chloride?
Emerging markets with limited manufacturing infrastructure and regulatory capacity may experience supply disruptions, emphasizing the importance of diversified suppliers.

5. How can healthcare providers ensure procurement security for Protopam Chloride?
Establishing agreements with multiple certified suppliers, maintaining strategic stockpiles, and engaging in government or international procurement programs can mitigate supply risks.

References

World Health Organization. (2022). Guidelines for the Procurement and Supply of Antidotes.
US Food and Drug Administration. (2023). List of Approved Antidotes.
Pfizer Inc. Corporate Website. (2023). Product Portfolio – Emergency Medicines.
Hetero Drugs Limited. Annual Reports and Certification. (2022).
Natco Pharma Ltd. Regulatory and Quality Certifications. (2022).

Suppliers and packagers for PROTOPAM CHLORIDE